Chen, Ling, and Steven M. Scharf. Systemic and myocardial hemodynamics during periodic obstructive apneas in sedated pigs. J. Appl. Physiol. 84(4): 1289-1298, 1998.-The effects of periodic obstructive apneas on systemic and myocardial hemodynamics were studied in nine preinstrumented sedated pigs under four conditions: breathing room air (RA), breathing 100% O 2 , breathing RA after critical coronary stenosis (CS) of the left anterior descending coronary artery, and breathing RA after autonomic blockade with hexamethonium (Hex). Apneas with RA increased mean arterial pressure (MAP; from baseline 103.0 Ϯ 3.5 to late apnea 123.6 Ϯ 7.0 Torr, P Ͻ 0.001) and coronary blood flow (CBF; late apnea 193.9 Ϯ 22.9% of baseline, P Ͻ 0.001) but decreased cardiac output (CO; from baseline 2.97 Ϯ 0.15 to late apnea 2.39 Ϯ 0.19 l/min, P Ͻ 0.001). Apneas with O 2 increased MAP (from baseline 105.1 Ϯ 4.6 to late apnea 110.7 Ϯ 4.8 Torr, P Ͻ 0.001). Apneas with CS produced similar increases in MAP as apneas with RA but greater decreases in CO (from baseline 3.03 Ϯ 0.19 to late apnea 2.1 Ϯ 0.15 l/min, P Ͻ 0.001). In LAD-perfused myocardium, there was decreased segmental shortening (baseline 11.0 Ϯ 1.5 to late apnea 7.6 Ϯ 2.0%, P Ͻ 0.01) and regional intramyocardial pH (baseline 7.05 Ϯ 0.03 to late apnea 6.72 Ϯ 0.11, P Ͻ 0.001) during apneas with CS but under no other conditions. Apneas with Hex increased to the same extent as apneas with RA. Myocardial O 2 demand remained unchanged during apnea relative to baseline. We conclude that obstructive apnea-induced changes in left ventricular afterload and CO are secondary to autonomicmediated responses to hypoxemia. Increased CBF during apneas is related to regional metabolic effects of hypoxia and not to autonomic factors. In the presence of limited coronary flow reserve, decreased O 2 supply during apneas can lead to myocardial ischemia, which in turn adversely affects left ventricular function. obstructive apnea; coronary blood flow; myocardial oxygen demand; hypoxemia; hexamethonium ACUTE AND CHRONIC cardiovascular disturbances are the most serious complications of obstructive sleep apnea (3, 21). These complications include elevations in blood pressure and left ventricular (LV) afterload, decreases in cardiac output (CO) and stroke volume (SV), oscillations in heart rate (HR), and pulmonary hypertension. In addition, myocardial ischemic disease including infarction can occur in patients with sleep apnea who also have coronary heart disease (21). Theoretically, increased LV afterload due to elevated blood pressure and increasingly negative swings in intrathoracic pressure, sympathoadrenal stimulation during apneas, and postapneic tachycardia should act synergistically to increase myocardial O 2 demand (MVO 2 ). On the other hand, apnea-associated bradycardia could decrease MVO 2 . By decreasing arterial O 2 content, hypoxemia would act to decrease O 2 content of blood perfusing the myocardium, thereby decreasing myocardial O 2 supply. Hence there is a tendency toward the development of an imbalance between myocardial O 2 supply and MVO 2 in patients with obstructive sleep apnea.
ACUTE AND CHRONIC cardiovascular disturbances are the most serious complications of obstructive sleep apnea (3, 21) . These complications include elevations in blood pressure and left ventricular (LV) afterload, decreases in cardiac output (CO) and stroke volume (SV), oscillations in heart rate (HR), and pulmonary hypertension. In addition, myocardial ischemic disease including infarction can occur in patients with sleep apnea who also have coronary heart disease (21) . Theoretically, increased LV afterload due to elevated blood pressure and increasingly negative swings in intrathoracic pressure, sympathoadrenal stimulation during apneas, and postapneic tachycardia should act synergistically to increase myocardial O 2 demand (MVO 2 ). On the other hand, apnea-associated bradycardia could decrease MVO 2 . By decreasing arterial O 2 content, hypoxemia would act to decrease O 2 content of blood perfusing the myocardium, thereby decreasing myocardial O 2 supply. Hence there is a tendency toward the development of an imbalance between myocardial O 2 supply and MVO 2 in patients with obstructive sleep apnea.
Normally, there is tight coupling between coronary blood flow (CBF) and MVO 2 (25) . Because myocardial O 2 extraction is normally large, the working myocardium generally meets the challenges of hypoxemia and increases in MVO 2 by increasing blood flow (25) . Therefore myocardial vasodilatory reserve is high. Under apneic conditions, CBF could be increased by regional metabolism, metabolic production of regional vasodilators, and/or ␤-adrenergic stimulation to the myocardium related to the overall sympathoadrenal response associated with apneas. On the other hand, ␣-adrenergic stimulation associated with the sympathoadrenal response to apneas could restrict the degree to which coronary vasodilation occurs during apneas (17) . It is difficult to measure the relationships among MVO 2 , CBF, and regional ischemia in patients with sleep apnea. Hence animal models have been developed to examine these factors (11, 19) . In one study on anesthetized animals, regional myocardial ischemia was observed during apneas when coronary vasodilatory reserve was limited (19) . However, the cardiovascular response in the anesthetized animals was different from that in sleep-apnea patients. Specifically, blood pressure decreased in the anesthetized animals during apneas, and anesthesia blunts the sympathoadrenal response to apneas and the degree to which intrathoracic pressure decreases during apneas.
We (5) have developed a preparation using sedated animals in which the hypertensive response during apnea is mimicked and swings in intrathoracic pressure during apneas are in the clinical range. We used this preparation to examine the relationships among arterial hypoxemia, CBF, MVO 2 , myocardial ischemia, and sympathoadrenal stimulation during apneas. We tested the following hypotheses: 1) during obstructive apneas (OAs), there is a substantial increase in both MVO 2 and CBF; 2) CBF increase is due to metabolic factors (e.g., hypoxemia and hypercapnia) rather than increased sympathetic tone; and 3) regional ischemia can develop during apneas if coronary vasodilator reserve is limited.
Instrumentation phase. Nine conditioned female Yorkshire farm pigs (Sus scrofa) weighing 16-22 kg were anesthetized with ketamine (4 mg/kg) and xylazine (2 mg/kg), intubated, and placed on mechanical ventilation with tidal volume of 12 ml/kg and respiratory rate of 15 breaths/min. Anesthesia was maintained using halothane (0.5-0.75%) in an O 2 -enriched mixture (35-45%) throughout surgery. HR and O 2 saturation were continuously monitored using a pulse oximeter attached to the ear. The animals were turned onto the right lateral decubitus position for left thoracotomy. By use of a sterile surgical technique, the chest was opened in the sixth left intercostal space, and the fifth rib was cut at or near the sternum. The pericardium was widely incised. Bretylium tosylate (100 mg iv) was administered to prevent arrhythmia when the pericardium and heart were manipulated.
The left anterior descending (LAD) coronary artery was identified distal to the first diagonal branch and was dissected free of the surrounding tissue. For measurement of LAD flow, a 1.5-or 2-mm hard-plastic Doppler flow probe (Crystal Biotech, Hopkinton, MA) was placed around the LAD artery, and the wire was secured to the myocardium. The blood flow signal was left uncalibrated. Previous studies (8, 10, 18) have established that the Doppler signal is proportional to blood flow within the physiological range, even in the presence of partial coronary occlusion upstream. We also assumed that LAD blood flow was representative of flow to the entire LV myocardium except with critical coronary stenosis (CS). Because, with CS, LAD flow could not be assumed to be representative of total flow, myocardial O 2 consumption could not be estimated under this condition (CS). A pneumatic balloon occluder (In Vivo Metric, Healdsburg, CA) was placed proximal to the flow probe, which served for precise control of the LAD lumen diameter using a threaded air-filled locking syringe attached to the balloon occluder.
By use of two pairs of sonomicrometer crystals (Crystal Biotech), regional LV myocardial shortening was measured in myocardium perfused by both the LAD and left circumflex (CFX) coronary arteries. LAD-or CFX-perfused myocardium was delimited by observation of coronary artery distribution and myocardial cyanosis secondary to 10-s occlusion of the LAD or CFX artery. The crystals in each pair were placed into the midmyocardium in the orientation of the superficial fibers, at a depth of 0.5 cm and a distance of 1.5-2.5 cm, and stabilized by suturing of an overlying mesh of 6-0 nylon. Regional myocardial ischemia leads to a severe decrease in percent regional shortening or even regional systolic lengthening (systolic bulging or negative shortening) (1) . The position of all crystals and probes was confirmed at autopsy after the experiments.
In this study, a Khuri tissue monitor system (Vascular Technologies, North Chelmsford, MA) was used to measure regional intramyocardial (extracellular) pH, which has been shown to correlate with histochemical markers of ischemia (8) . With use of this system, preliminary studies in our laboratory have shown that the drift was Յ0.1 pH unit over 6 h, and the 95% response time to a step change was 15 s (18) . For measurement of the pH of myocardium perfused by the LAD and CFX arteries, pH and temperature probes were inserted into and secured to myocardium perfused by these vessels, respectively, close to the sonomicrometer crystal pairs. Regional CFX-perfused myocardial pH and contraction served as controls for LAD-perfused myocardium during experiments on regional restriction of coronary vasodilator reserve (see below).
The coronary sinus and great cardiac vein were identified. If collateral venous connections to the great cardiac vein and coronary sinus from the hemiazygous vein were identified, these venous connections were ligated. For measurement of blood-gas tensions of the coronary sinus, by use of a Seldinger technique, a small heparin-filled catheter sealed with a plastic plug, guided with a bent 16-gauge needle, was tunneled through the myocardium into one branch of the great cardiac vein and advanced into the coronary sinus approximately at the junction of the coronary sinus and the great cardiac vein. Blood-gas samples were taken from the catheter and the right atrium to verify the position of the catheter. The catheter was secured by suture.
A heparin-filled plastic catheter sealed with a plastic plug was inserted into the left atrial appendage and secured by purse-string suture. At the data-collection phase (see below), this catheter served for injection for thermodilution CO measurement and insertion of an LV catheter. For continuous measurement of CO, the ascending aorta was separated from the pulmonary artery, and a sterile square-wave electromagnetic flow probe (Biotronix Manufacturing) was placed around the ascending aorta (size 14-18 mm depending on aortic diameter).
A 2-cm-long latex balloon, on the end of multihole polyethylene PE-100 tubing, was placed along the lateral surface of the left lung for measurements of intrathoracic pressure. This balloon system has been used and validated previously in this laboratory (18, 19) . A volume of air put into the balloon was the least volume on the flat portion of the pressure-volume curve of the balloon.
The wires and catheters were wrapped in plastic, brought through the chest wall, and placed in a subcutaneous pocket. A chest tube was placed percutaneously. The thoracotomy was closed in layers. The chest was then evacuated by using positive pressure, and the chest tube was removed. The animal was allowed to awaken and was placed in an individual pen. Antibiotic prophylaxis with penicillin (24,000 U/kg im) and dihydrostreptomycin (30 mg/kg im) was administered at surgery and on the following day. Morphine sulfate (5 mg im) was given every 6 h during the first 24 h for pain control.
Data collection phase. Five to seven days after initial surgery, the animals were anesthetized with an injection of ketamine (2 mg/kg im) and were monitored with a pulse oximeter. This induced 30-40 min of surgical anesthesia. Animals were intubated and mechanically ventilated. Tidal volume was set to 10 ml/kg, and respiratory frequency was adjusted to maintain arterial PCO 2 in the physiological range.
With the pig under local anesthesia with 2% lidocaine, a large-bore catheter was placed via cutdown into the right femoral vein for administration of fluids and medications. A 7-F thermistor-tipped catheter was inserted into the femoral artery and advanced into the ascending aorta for measurement of mean arterial pressure (MAP), measurement of CO by thermodilution, and blood-gas sampling.
The subcutaneous pocket was opened under local anesthesia, and the wires and catheters were exposed. The end of the left atrial catheter was exposed, and the plastic plug was replaced with a plastic head with a one-way valve and sidearm, which served for insertion of a 5-F micrometertipped catheter (Millar Instrument, Houston, TX) into the LV for high-fidelity recording of LV pressure. The aortic flow probe was calibrated against simultaneous measurements by thermodilution, in which 5 ml of iced saline were injected into the left atrium via the sidearm of the left atrial catheter and blood temperature was sampled via the femoral arterial catheter.
The cutdowns were closed, and the animal was placed on its right side. A continuous intravenous drip with a mixture of 0.9% alfaxolone and 0.3% alfadolone (Saffan, Pittman-Moore, Oxbridge, Middlesex, UK; 3 mg · kg Ϫ1 ·h Ϫ1 total steroid) was instituted. This served to maintain a constant level of sedation once the animals came out of the surgical plane of anesthesia.
Experimental protocols. OAs were caused by occluding the endotracheal tube for 30 s at end expiration (apnea phase) and then releasing the occlusion to allow spontaneous breathing for 30 s (interapnea interval). An apneic-interapneic cycle was thus defined as the 1 min that it took to allow apneic phase and interapneic interval. Eight cycles were repeated for each specified condition before data were collected.
We tested the effects of OA under the following four conditions: 1) room air breathing (RA); 2) 100% O 2 administered to the endotracheal tube (O 2 ); 3) RA after CS of the LAD artery (CS); and 4) RA after hexamethonium (Hex; 5 mg/kg). Preliminary studies demonstrated that the dose of Hex used here was enough to produce maximal autonomic blockade in these studies. CS was produced as follows. First, vasodilatory flow reserve in the LAD artery was confirmed by observing a vigorous hyperemic response after 10 s of complete LAD coronary occlusion produced by using the balloon occluder. Once LAD flow had returned to baseline, the 10-s complete occlusion was repeated. At the end of this time, air was slowly withdrawn from the pneumatic occluder until LAD flow returned to a level no greater than the preocclusion level. Thus critical CS was defined functionally as stenosis sufficient to abolish the LAD flow reserve but to keep the flow within 15% of its preocclusion level. The meaning of the word ''critical'' is that vasodilatory reserve is lost, since the coronary bed distal to the stenotic segment is already maximally dilated, but CBF is maintained. A consequence of the technique is that normal coronary autoregulation is abolished.
Data collection and analysis. Data, including arterial and coronary sinus blood gases, intrathoracic pressure, aortic blood pressure, CO, LAD flow, regional myocardial pH, and segmental shortening (in myocardium perfused both by LAD and CFX arteries), were sampled at a frequency of 100 Hz in 60-s epochs and streamed through to a hard disk of a microcomputer using commercially available software (ACQ4600, Gould, Cleveland, OH). Recordings were made at baseline, during the eighth apneic-interapneic cycle under each experimental condition, and at recovery. We use the term ''baseline'' to indicate the period preceding experimentally induced apneas, during which all cardiovascular variables were stable for at least 20 min. ''Recovery'' means 20 min after apnea cessation, i.e., the same as baseline conditions. Comparison of baseline and recovery data therefore allow assessment of time-related changes. During the eighth apneic-interapneic cycle, intrathoracic pressure and hemodynamics were recorded over the entire cycle. One measurement of myocardial pH and arterial and coronary sinus blood gases was taken from 5 s before apnea termination to 5 s into the following interapneic interval.
Data were analyzed off-line by using commercially available software (View II, Gould). The following times were specified during the eighth apneic-interapneic cycle: early apnea (1st 5 s of apneic phase), late apnea (last 5 s of apneic phase), early interapnea (1st 5 s of interapneic interval), and late interapnea (last 5 s of interapneic interval).
HR and MAP were measured from the blood pressure tracing, CO from the aortic flow tracing calibrated from the thermodilution measurements, and mean LAD flow from the LAD flow probe. SV was calculated as CO divided by HR. Coronary vascular resistance (CVR) of the myocardial region perfused by the LAD artery was estimated as the difference between MAP and mean right atrial pressure divided by LAD flow. Systemic vascular resistance (SVR) was calculated as (MAP/CO) ϫ 79.9 dyn·s·cm Ϫ5 . MVO 2 was calculated as the difference in arterial O 2 content between arterial and coronary sinus blood multiplied by LAD flow. For each pair of crystals (in LAD and CFX area), we measured regional myocardial lengths at end diastole (EDL) and end systole (ESL). Percent fiber shortening was calculated as [(EDL Ϫ ESL)/EDL] ϫ 100. End diastole was defined as the point of rapid upstroke of the LV pressure tracing. End systole was defined as the zero crossing of the aortic flow after ejection.
Data were compiled and expressed as means Ϯ SE. LAD flow, CVR, and MVO 2 were normalized to baseline values. For each condition, statistical significance was tested using oneway ANOVA for repeated measures. If significance was found, a Newman-Keuls procedure was used to analyze the difference between each pair of values. Two-way ANOVA was used to assess statistical significance of differences between conditions. The null hypothesis was rejected at the 5% level.
RESULTS
There were no significant differences between baseline and recovery in any respiratory or hemodynamic variables for any conditions. Thus the preparation demonstrated no time-related deterioration.
Intrathoracic pressure and blood-gas tensions. Table  1 demonstrates the changes in maximal intrathoracic pressure swings and blood-gas tensions. During apnea, all conditions were associated with similarly exagger- Values are means Ϯ SE. RA, room air breathing; O 2 , breathing 100% O 2 ; CS, breathing room air after critical coronary stenosis; Hex, breathing room air after hexamethonium; ITP, maximal intrathoracic pressure. ITP was measured during late apnea of 8th apneic-interapneic cycle. Arterial blood-gas samples were taken during 10-s period from late apnea to early interapnea of 8th apneic-interapneic cycle. * P Ͻ 0.01, compared with baseline. http://jap.physiology.org/ ated inspiratory swings in intrathoracic pressure (31-36 Torr) and a similar degree of hypercapnia and decreases in pH. In the three conditions with room air (RA, CS, and Hex), OAs led to moderate hypoxemia. However, there was no hypoxemia during apneas with O 2 supplementation (O 2 ).
Systemic hemodynamics and global cardiac function. MAP (Fig. 1) increased significantly relative to baseline at all points of the apneic-interapneic cycle with RA, CS, and O 2 (both P Ͻ 0.001) but not with Hex. MAP was significantly higher with RA than with O 2 (P Ͻ 0.05) and significantly lower with Hex than in the other three conditions (P Ͻ 0.001, respectively). Relative to baseline, HR (Fig. 2) increased significantly with RA at late interapnea (P Ͻ 0.05) and with Hex at all points of the cycle (P Ͻ 0.001) but remained unchanged relative to baseline with O 2 and CS. Over the cycle, there were significant differences in HR between late apnea (lowest) and late interapnea (highest) in all the conditions (P Ͻ 0.05, respectively) except CS. With Hex, baseline HR was significantly greater than in the other three conditions (P Ͻ 0.01, respectively). Both CO (Fig. 3) and SV (Fig. 4) decreased significantly relative to baseline at late apnea and early interapnea with RA (both P Ͻ 0.001) and at all points over the apneic-interapneic cycle with CS (both P Ͻ 0.001). The changes in CO (P Ͻ 0.05) and SV (P Ͻ 0.01) were greater with CS than with RA. CO and SV remained unchanged during the cycle relative to baseline with O 2 or Hex, although Hex was associated with higher CO at baseline than in the other three conditions (P Ͻ 0.001, respectively). Relative to baseline, SVR (Fig. 5 ) increased significantly at all points in the apnea-interapnea cycle and under all conditions except Hex. With Hex, baseline SVR was decreased compared with the other conditions (P Ͻ 0.001), and there was no change in SVR with apneas.
LAD flow and CVR. Normalized LAD flow (Fig. 6 ) increased significantly at all the points of the apneicinterapneic cycle with both RA and Hex relative to baseline (both P Ͻ 0.001) except at early apnea with RA. There were no significant differences between RA and Hex. There was no significant change in LAD flow Fig. 1 . Effects of periodic obstructive apneas on mean arterial pressure. RA, room air breathing; O 2 , breathing O 2 ; CS, breathing room air after critical coronary stenosis; Hex, breathing room air after hexamethonium; Base, baseline; EAP, early apnea; LAP, late apnea; EIA, early interapnea; LIA, late interapnea; Recov, recovery. Data are means Ϯ SE; each datum point represents 5 s of data. **Significance compared with baseline, P Ͻ 0.01. Note that some SE bars were not shown to avoid overlapping. over the apneic-interapneic cycle with O 2 and CS. As noted above, with CS, LAD flow cannot reflect changes in global CBF, and we cannot calculate CVR and MVO 2 with CS. Normalized CVR (Fig. 7) decreased significantly at all points of the apneic-interapneic cycle with Hex (P Ͻ 0.001) and at late apnea and early interapnea with RA (P Ͻ 0.001). There were no significant differences between RA and Hex in maximal CVR change, although, with Hex, the maximal decrease in CVR occurred in late apnea and, with RA, the maximal change occurred in early interapnea. CVR remained unchanged during the apneas with O 2 .
MVO 2 . In six pigs, we successfully obtained blood samples from the coronary sinus. Figure 8 shows that there was no significant change in MVO 2 during apnea relative to baseline in the three experimental conditions in which this could be calculated (RA, O 2 , and Hex). Regional function. Figure 9 shows regional myocardial contractile function expressed as segmental shortening for LAD-and CFX-perfused myocardium. Segmental shortening significantly decreased during apneas only in LAD-perfused myocardium with CS (P Ͻ 0.01). With RA, O 2 , and Hex, there were no significant changes in either region, and there were no changes in regional shortening in CFX-perfused myocardium with CS of the LAD artery.
Regional intramyocardial pH. Regional intramyocardial pH is presented in Fig. 10 . In CFX-perfused myocardium, there were no significant changes under any conditions. During apneas, regional pH decreased significantly only in LAD-perfused myocardium with CS.
DISCUSSION
There are four major findings of the present study: 1) CO decreased and LV afterload increased during OA with RA and CS, a response that was abolished with O 2 and Hex; 2) during apneas, LAD flow increased and CVR decreased with RA and Hex but were unchanged with O 2 ; 3) during apneas, MVO 2 remained unchanged even though LV afterload increased; and 4) with CS, OAs caused regional myocardial ischemia, as indicated by decreased intramyocardial pH and segmental shortening of LAD-perfused myocardium. The ensuing discussion considers these points in the light of the limits of the experimental preparation and currently available literature.
Experimental preparation. The present model allowed us to continuously measure CBF and global and regional LV functional responses to OAs on a beat-tobeat basis. It demonstrated good stability over time, as shown by the fact that there were no differences in any cardiorespiratory parameters between baseline and recovery.
Because the model utilized preinstrumented sedated pigs, cardiorespiratory depression caused by anesthesia and major surgery was minimized. Thus swings in intrathoracic pressure with OA were greater than those seen in the anesthetized dog model (19) and were comparable to those seen in sleep-apnea patients (13) . Compared with some other sedative-anesthetics, alfaxolone-alfadolone produces less suppression of baroreceptor and chemoreceptor function (2) . In the doses used here, there is preservation of corneal reflexes, spontaneous ventilation, and responses to very loud noises and severely painful stimuli. In our previous study (5), we also doubled the dose of alfaxolone-alfadolone in several animals and observed the same response in MAP and HR to apneas, suggesting that the changes seen were not due to a nonspecific response to pain or http://jap.physiology.org/ discomfort or being inadequately sedated. However, although the present model reproduces many of the features of human OA (large swings in intrathoracic pressure, periodic hypoxemia, increased LV afterload, and decreased CO), in our previous study, electroencephalograph (EEG) monitoring suggested that there was no postapneic arousal phase, and changes due to changing sleep state are not observed (4). Thus changes in MVO 2 and CBF related to these factors are not seen in the present model and should be considered an additional strain on the myocardium in human disease.
Systemic hemodynamics and global cardiac function. Here we discuss the global changes seen with RA, O 2 , and Hex. Apnea-induced changes under the CS conditions are discussed below.
As demonstrated in our previous study (5), OA during RA was associated with a marked increase in LV afterload as indicated by MAP and SVR and an ϳ20% decrease in CO and SV at late apnea compared with baseline. Eliminating hypoxemia (O 2 ) and autonomic blockade (Hex) resulted in the diminution of the increase in LV afterload and blunting of the CO and SV response. These findings indicate that the mechanism responsible for decreased CO and SV was the increase in LV afterload expressed as MAP and/or SVR. Although detailed studies of contractility were not done, absence of a change in segmental shortening during apneas is consistent with absence of change in myocardial contractility as a cause of decreased SV. As in the present study, many previous clinical and experimental studies have observed an inverse correlation between oxyhemoglobin saturation and MAP during apneas (3). Thus our results are consistent with data demonstrating that the primary stimulus to increased MAP during apneas is hypoxemia.
As in our previous study using paralyzed pigs (5), the present study also showed that, with O 2 , there was a small residual increase in MAP during apneas, suggesting that factors besides hypoxemia can play a role in the hypertensive response to apneas. The stimulus for the hypertensive response during hyperoxic apneas is not clear. There was no sign of arousal observed in this model by monitoring the EEG (our unpublished data). Although hypercapnia can lead to increased MAP, it also leads to increased HR, decreased SVR, decreased myocardial dimensions, and increased CO (4) . Because none of these secondary findings were present during apneas with O 2 , it is unlikely that hypercapnia is the hypertensive stimulus during apneas in this model. However, alterations in thoracic mechanoreceptor or central circulatory reflexes could possibly have influenced MAP during apneas in our model.
Slowing of HR during late apnea compared with the early part of apnea of end interapnea is well known in OA patients (7, 13, 24, 27) and animal models (6) . This slowing is related to enhanced vagal tone related at least in part to hypoxemia (22) . Postapneic increases in HR are related to both resumption of ventilation and arousal (7) . The responses that we observed are consistent with these studies in that, during the apneicinterapneic cycle, minimal HR was immediately before resumption of ventilation (late apnea). Zwillich et al. (27) suggested that the bradycardia of OA was correlated to the severity of hypoxemia. In the present study, the difference in HR between late interapnea and late apnea was not significant with O 2 , results consistent with the postulate of Zwillich et al. (27) . Hypoxia could lead to HR slowing through secondary baroreceptor responses as well as primary vagal stimulation via the carotid chemoreceptors (22) .
After autonomic blockade with Hex, we observed a rise in baseline HR and a further rise in HR during apneas. The rise in baseline HR could have been due to withdrawal of vagal tone because of autonomic ganglionic blockade. The reasons for the secondary increase in HR during apneas with Hex are not as clear. Hex has been shown to prevent ganglionic neurotransmission by interfering with the postsynaptic action of acetylcholine either through nicotinic receptors or through ionic channels (26) . However, Hex does not antagonize postganglionic muscarinic receptors that may mediate a slow excitatory postsynaptic potential (26) . It has been postulated that, in the presence of ganglionic blocking drugs, postganglionic muscarinic receptors may take over the functional role of ganglionic neurotransmission normally carried out by the nicotinic receptor (26) . These may possibly have cardiovascular effects. Furthermore, we have previously observed systemic catecholamine release during apneas even after Hex (6), although the site of release is unknown. Additionally, there may be a local metabolic release of catecholamines from myocardium independent of central sympathetic activation (20) . Finally, there may be release of catecholamines from autonomic ganglia. This is because Hex does not antagonize the muscarinic receptors on small, intensely fluorescent cells in autonomic ganglia and such cells release catecholamines as their neurotransmitter (26) . Thus increased HR during apneas with Hex could relate to catecholamine release at any of a number of sites unopposed by vagal tone.
Clinical studies have suggested increased activity of the sympathetic nervous system in obstructive sleepapnea patients (3, 9, 23) . Furthermore, relatively brief periods of asphyxia (i.e., Mueller maneuver and breath hold) also substantially increase sympathetic activity (14) . Data suggest that increased sympathoadrenal activity is a cause of hypertension (3) and thus may be a cause of high cardiovascular morbidity and mortality in these patients. Treatment with continuous positive airway pressure is associated with decreased muscular sympathetic activity (23) and plasma catecholamine levels (9) . The present study also demonstrates the primary sympathoadrenal response during OA, since Hex eliminated OA-induced changes in MAP, SVR, CO, and SV. Thus sympathetic activation is the major mechanism mediating the cardiovascular responses to OA. These include increased LV afterload (MAP), which leads to decreased CO and SV.
LAD flow and CVR. With RA, LAD flow rose 86% and calculated CVR fell 43% at early interapnea relative to baseline. Because both the responses were completely eliminated with O 2 supplementation, LAD flow response during OAs is primarily determined by hypoxemia. Furthermore, because the changes in CVR and CBF during apneas with Hex were the same as those with RA, there appears to be little role for sympathetic stimulation in the determination of CBF during apneas. Thus the changes in CBF and CVR during apneas are mediated by hypoxia, probably through production of vasoactive mediators or direct effects of hypoxia. In a study on inspiratory loading from this laboratory, small increases in CBF were observed during exaggerated inspiratory efforts in the absence of hypoxia (10) . In that previous study, however, increased coronary flow was attributed to hypercapnia, which was considerably greater (60-66 Torr) than observed in the present study. Thus the absence of coronary vasodilation during hyperoxic apneas (O 2 ) is not inconsistent with these previous results. Possibly, had hyperoxic apneas been associated with greater hypercapnia, some coronary vasodilation would have been observed. In sleeping pigs, Pinto et al. (16) reported no significant change in LAD flow during brief periods (10 s) of upper airway occlusion. Although these data appear contradictory to the present study, O 2 saturation was not assessed in the Pinto study. Furthermore, the authors themselves stated that ''it is unlikely that...pigs developed hypoxemia during the...induced occlusion.'' Thus it is unlikely that the pigs in the Pinto study were hypoxic enough to lead to changes in CBF.
It has been suggested that shifts in ␤-adrenergic tone during sleep can be responsible for sleep stage-related changes in CBF (11, 12) . Indeed, CBF increases during arousal from apnea can be eliminated with ␤-adrenoreceptor blockade (12) . In the latter study (12) , there was no marked desaturation during apnea, suggesting that sympathoadrenal tone determines CBF during sleep stage shifts. As already stated, our model does not permit assessment of this aspect of sleep apnea. However, sleep stage-related shifts in CBF were far smaller (13-22% increase in CBF) than hypoxemia-related changes in CBF observed in the present study. Thus the major changes in CBF during human sleep apnea are most likely related to local myocardial effects of hypoxemia.
MVO 2 . We found no significant change in MVO 2 during apnea relative to baseline. Theoretically, MVO 2 should be a function of HR and afterload (25) . Under all conditions in which MVO 2 could be measured (RA, O 2 , and Hex), there were increases in one or both of these factors during apneas. Furthermore, increases in LV afterload related to large negative swings in intrathoracic pressure during apneas might also have been expected to increase MVO 2 (15) . Thus it is unexpected that we failed to find increased MVO 2 during apneas in our study.
First, with regard to the effect of negative swings in intrathoracic pressure during apneas, our data are consistent with previous data in anesthetized animals during inspiratory resistive loading (10) . In those previous studies, failure to find increased MVO 2 was attributed to the fact that overall mean intrathoracic pressure changed little despite exaggerated inspiratory swings. It is possible that similar factors were operative here. Even though there were exaggerated decreases in intrathoracic pressure during apneas, overall inspiratory time was usually less than one-third of the total cycle time and mean intrathoracic pressure probably changed little. Another factor influencing the measurement of MVO 2 could have been the fact that myocardial venous blood was withdrawn over only part of the apneic-interapneic cycle. In some of experiments, however, coronary sinus blood was also withdrawn over the entire apnea cycle, with no change in the calculated MVO 2 . During hypoxemia, there may be an increase in the efficiency of myocardial O 2 utilization so that a given work load may be accomplished at lower MVO 2 (25) . Thus increased myocardial work during RA apneas, when changes in MAP were the greatest, may not have been associated with increased MVO 2 . Changes in MAP and HR during O 2 and Hex conditions were relatively small as a percentage of baseline and might not have been expected to produce large changes in MVO 2 . Finally, decreased SV can lead to decreased MVO 2 (25) . This may have counterbalanced the tendency for MVO 2 to increase during RA apneas.
